ANNX
Price
$6.50
Change
-$0.18 (-2.69%)
Updated
Jan 15, 11:10 AM (EDT)
Capitalization
995.69M
53 days until earnings call
Intraday BUY SELL Signals
SYRE
Price
$33.48
Change
+$0.33 (+1.00%)
Updated
Jan 15, 12:12 PM (EDT)
Capitalization
2.57B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANNX vs SYRE

Header iconANNX vs SYRE Comparison
Open Charts ANNX vs SYREBanner chart's image
Annexon
Price$6.50
Change-$0.18 (-2.69%)
Volume$7.03K
Capitalization995.69M
Spyre Therapeutics
Price$33.48
Change+$0.33 (+1.00%)
Volume$122
Capitalization2.57B
ANNX vs SYRE Comparison Chart in %
ANNX
Daily Signal:
Gain/Loss:
SYRE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANNX vs. SYRE commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Hold and SYRE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ANNX: $6.68 vs. SYRE: $33.16)
Brand notoriety: ANNX and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 148% vs. SYRE: 139%
Market capitalization -- ANNX: $995.69M vs. SYRE: $2.57B
ANNX [@Biotechnology] is valued at $995.69M. SYRE’s [@Biotechnology] market capitalization is $2.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, ANNX is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 4 TA indicator(s) are bullish while SYRE’s TA Score has 3 bullish TA indicator(s).

  • ANNX’s TA Score: 4 bullish, 4 bearish.
  • SYRE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANNX is a better buy in the short-term than SYRE.

Price Growth

ANNX (@Biotechnology) experienced а +20.80% price change this week, while SYRE (@Biotechnology) price change was +6.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 09, 2026.

SYRE is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($2.57B) has a higher market cap than ANNX($996M). ANNX YTD gains are higher at: 33.068 vs. SYRE (1.221). ANNX (-216.47M) and SYRE (-223.64M) have comparable annual earnings (EBITDA) . SYRE has more cash in the bank: 486M vs. ANNX (189M). SYRE has less debt than ANNX: SYRE (0) vs ANNX (26.9M). ANNX (0) and SYRE (0) have equivalent revenues.
ANNXSYREANNX / SYRE
Capitalization996M2.57B39%
EBITDA-216.47M-223.64M97%
Gain YTD33.0681.2212,708%
P/E RatioN/A1.72-
Revenue00-
Total Cash189M486M39%
Total Debt26.9M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXSYRE
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signal:
Gain/Loss:
SYRE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECOIX10.840.05
+0.46%
Redwheel Next Generation Power InfrasIns
OILVX20.310.06
+0.30%
Optimum Large Cap Value Instl
PQIAX42.190.10
+0.24%
Principal Equity Income A
BGATX13.70-0.09
-0.68%
Baillie Gifford Global Alpha Equities 2
UGPIX27.88-0.58
-2.04%
ProFunds UltraChina Inv

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with RLAY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+7.92%
RLAY - ANNX
42%
Loosely correlated
+1.64%
NRIX - ANNX
42%
Loosely correlated
+0.58%
SYRE - ANNX
41%
Loosely correlated
+5.17%
CRNX - ANNX
41%
Loosely correlated
+2.04%
VYGR - ANNX
41%
Loosely correlated
+2.74%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with ORKA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+5.17%
ORKA - SYRE
58%
Loosely correlated
+2.11%
XNCR - SYRE
58%
Loosely correlated
+3.66%
BEAM - SYRE
57%
Loosely correlated
+2.49%
RGNX - SYRE
56%
Loosely correlated
-0.66%
APGE - SYRE
55%
Loosely correlated
+4.34%
More